Patients with hematologic malignancies (HM) nowadays rarely receive palliative or hospice care, and studies on potential effects of integrated palliative care are rare. This narrative review provides a comprehensive overview on their current end-of-life care, first data on integrated specialist palliative care (SPC) and potential barriers. Symptom burden and distress in patients with HM seem to be comparable to other cancer patients, but their performance status and specific symptoms are even worse. Prolongation of life usually remains the main focus until the last days or weeks of life. Their chance to die in hospital is twice as high, but their chance to receive specialist palliative or hospice care is only half of that of other cancer patients. Prospective studies indicate a high acceptability and positive effects of integrated SPC, e.g. clarification of treatment goals, stabilization of quality of life, decreased depression, anxiety, symptom burden, and post-traumatic stress disorders. Interdisciplinary cooperation, timely discussions about SPC referral, and indicators to ‘flag' patients in need for SPC are important, but they are largely missing. In conclusion, further studies have to evaluate factors identifying patients with HM in need for SPC. Further models of early integrated palliative care should be evaluated in prospective studies and established in daily clinical practice.

Journal Section:
Review Article
Keywords:
Depression, Early integration, Palliative care, Research methodology, Supportive care
1.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ: Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2017;35:96-112.
[PubMed]
https://doi.org/10.1200/JCO.2016.70.1474
2.
Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J: The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage 2011;42:432-442.
[PubMed]
https://doi.org/10.1016/j.jpainsymman.2010.12.008
3.
Moreno-Alonso D, Porta-Sales J, Monforte-Royo C, Trelis-Navarro J, Sureda-Balarí A, Fernández De Sevilla-Ribosa A: Palliative care in patients with hematological neoplasms: an integrative systematic review. Palliat Med 2018;32:79-105.
[PubMed]
https://doi.org/10.1177/0269216317735246
4.
LeBlanc TW, Abernethy AP, Casarett DJ: What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage 2015;49:505-512.
[PubMed]
https://doi.org/10.1016/j.jpainsymman.2014.07.003
5.
Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E: Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 2008;11:422-427.
[PubMed]
https://doi.org/10.1089/jpm.2007.0184
6.
Hung YS, Wu JH, Chang H, Wang PN, Kao CY, Wang HM, Liau CT, Chen JS, Lin YC, Su PJ, Hsieh CH, Chou WC: Characteristics of patients with hematologic malignancies who received palliative care consultation services in a medical center. Am J Hosp Palliat Care 2013;30:773-780.
[PubMed]
https://doi.org/10.1177/1049909112471423
7.
Hochman MJ, Yu Y, Wolf SP, Samsa GP, Kamal AH, LeBlanc TW: Comparing the palliative care needs of patients with hematologic and solid malignancies. J Pain Symptom Manage 2018;55:82-88.e1.
[PubMed]
https://doi.org/10.1016/j.jpainsymman.2017.08.030
8.
Ruiz M, Reynolds P, Marranzini R, Khan A, Ketterer J, Brahim A: Role of early palliative care interventions in hematological malignancies and bone marrow transplant patients: barriers and potential solutions. Am J Hosp Palliat Care 2018;35:1456-1460.
[PubMed]
https://doi.org/10.1177/1049909118772849
9.
Epstein AS, Goldberg GR, Meier DE: Palliative care and hematologic oncology: the promise of collaboration. Blood Rev 2012;26:233-239.
[PubMed]
https://doi.org/10.1016/j.blre.2012.07.001
10.
Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR: Hematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med 2011;25:630-641.
[PubMed]
https://doi.org/10.1177/0269216310391692
11.
Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, Bruera E: Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 2014;120:1572-1578.
[PubMed]
https://doi.org/10.1002/cncr.28614
12.
Cheng BH, Sham MM, Chan KY, Li CW, Au HY: Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life. Am J Hosp Palliat Care 2015;32:221-225.
[PubMed]
https://doi.org/10.1177/1049909113512412
13.
Brück P, Pierzchlewska M, Kaluzna-Oleksy M, Ramos Lopez ME, Rummel M, Hoelzer D, Böhme A: Dying of hematologic patients - treatment characteristics in a German university hospital. Support Care Cancer 2012;20:2895-2902.
[PubMed]
https://doi.org/10.1007/s00520-012-1417-8
14.
Odejide OO, Cronin AM, Condron N, Earle CC, Wolfe J, Abel GA: Timeliness of end-of-life discussions for blood cancers: a national survey of hematologic oncologists. JAMA Intern Med 2016;176:263-265.
[PubMed]
https://doi.org/10.1001/jamainternmed.2015.6599
15.
El-Jawahri AR, Abel GA, Steensma DP, LeBlanc TW, Fathi AT, Graubert TA, DeAngelo DJ, Wadleigh M, Ballen KK, Foster JE, Attar EC, Amrein PC, Brunner AM, Stone RM, Temel JS: Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer 2015;121:2840-2848.
[PubMed]
https://doi.org/10.1002/cncr.29430
16.
Cheng HW, Li CW, Chan KY, Au HY, Chan PF, Sin YC, Szeto Y, Sham MK: End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia. Support Care Cancer 2015;23:111-116.
[PubMed]
https://doi.org/10.1007/s00520-014-2333-x
17.
Freeman AT, Wood WA, Fox A, Hanson LC: Access to palliative care consultation and advance care planning for adults with high-risk leukemia. J Palliat Med 2018;21:225-228.
[PubMed]
https://doi.org/10.1089/jpm.2017.0097
18.
Boucher NA, Johnson KS, LeBlanc TW: Acute leukemia patients' needs: qualitative findings and opportunities for early palliative care. J Pain Symptom Manage 2018;55:433-439.
[PubMed]
https://doi.org/10.1016/j.jpainsymman.2017.09.014
19.
Ramsenthaler C, Osborne TR, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ: The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 2016;16:427.
[PubMed]
https://doi.org/10.1186/s12885-016-2410-2
20.
Ansell P, Howell D, Garry A, Kite S, Munro J, Roman E, Howard M: What determines referral of UK patients with hematological malignancies to palliative care services? An exploratory study using hospital records. Palliat Med 2007;21:487-492.
[PubMed]
https://doi.org/10.1177/0269216307082020
21.
Howell DA, Wang HI, Roman E, Smith AG, Patmore R, Johnson MJ, Garry AC, Howard MR: Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma. BMJ Support Palliat Care 2015;5:496-502.
[PubMed]
https://doi.org/10.1136/bmjspcare-2013-000578
22.
Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, Sarrà-Escarré J, Clapés-Puig V, Trelis-Navarro J, Sureda-Balarí A, Fernández De Sevilla-Ribosa A: Is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manage 2017;54:692-700.
[PubMed]
https://doi.org/10.1016/j.jpainsymman.2017.04.012
23.
Kaiser F, Rudloff LV, Vehling-Kaiser U, Hollburg W, Nauck F, Alt-Epping B: Palliative home care for patients with advanced hematological malignancies-a multicenter survey. Ann Hematol 2017;96:1557-1562.
[PubMed]
https://doi.org/10.1007/s00277-017-3045-3
24.
McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD, Howard MR, Howell DA: Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study. BMC Palliat Care 2018;17:33.
[PubMed]
https://doi.org/10.1186/s12904-018-0289-1
25.
Odejide OO, Cronin AM, Earle CC, Tulsky JA, Abel GA: Why are patients with blood cancers more likely to die without hospice? Cancer 2017;123:3377-3384.
[PubMed]
https://doi.org/10.1002/cncr.30735
26.
Hopkins B, Gold M, Wei A, Grigoriadis G: Improving the transition to palliative care for patients with acute leukemia: a coordinated care approach. Cancer Nurs 2017;40:E17-E23.
[PubMed]
https://doi.org/10.1097/NCC.0000000000000368
27.
Loggers ET, LeBlanc TW, El-Jawahri A, Fihn J, Bumpus M, David J, Horak P, Lee SJ: Pretransplantation supportive and palliative care consultation for high-risk hematopoietic cell transplantation patients. Biol Blood Marrow Transplant 2016;22:1299-1305.
[PubMed]
https://doi.org/10.1016/j.bbmt.2016.03.006
28.
El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS: Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 2016;316:2094-2103.
[PubMed]
https://doi.org/10.1001/jama.2016.16786
29.
El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, Pirl WF, Jackson VA, Telles J, Rhodes A, Li Z, Spitzer TR, McAfee S, Chen YA, Temel JS: Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol 2017;35:3714-3721.
[PubMed]
https://doi.org/10.1200/JCO.2017.73.2800
30.
Hui D, Bansal S, Park M, Reddy A, Cortes J, Fossella F, Bruera E: Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists. Ann Oncol 2015;26:1440-1446.
[PubMed]
https://doi.org/10.1093/annonc/mdv028
31.
LeBlanc TW, O'Donnell JD, Crowley-Matoka M, Rabow MW, Smith CB, White DB, Tiver GA, Arnold RM, Schenker Y: Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 2015;11:e230-e238.
[PubMed]
https://doi.org/10.1200/JOP.2014.001859
32.
Wright B, Forbes K: Haematologists' perceptions of palliative care and specialist palliative care referral: a qualitative study. BMJ Support Palliat Care 2017;7:39-45.
[PubMed]
https://doi.org/10.1136/bmjspcare-2014-000689
33.
Odejide OO, Cronin AM, Condron NB, Fletcher SA, Earle CC, Tulsky JA, Abel GA: Barriers to quality end-of-life care for patients with blood cancers. J Clin Oncol 2016;34:3126-3132.
[PubMed]
https://doi.org/10.1200/JCO.2016.67.8177
34.
Morikawa M, Shirai Y, Ochiai R, Miyagawa K: Barriers to the collaboration between hematologists and palliative care teams on relapse or refractory leukemia and malignant lymphoma patients' care: a qualitative study. Am J Hosp Palliat Care 2016;33:977-984.
[PubMed]
https://doi.org/10.1177/1049909115611081
35.
LeBlanc TW, El-Jawahri A: When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program 2015;2015:471-478.
[PubMed]
https://doi.org/10.1182/asheducation-2015.1.471
36.
Hudson KE, Wolf SP, Samsa GP, Kamal AH, Abernethy AP, LeBlanc TW: The surprise question and identification of palliative care needs among hospitalized patients with advanced hematologic or solid malignancies. J Palliat Med 2018;21:789-795.
[PubMed]
https://doi.org/10.1089/jpm.2017.0509
37.
Efficace F, Cartoni C, Niscola P, Tendas A, Meloni E, Scaramucci L, Soldati S, Brunetti GA, Marini MG, Mandelli F: Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? Eur J Haematol 2012;89:410-416.
[PubMed]
https://doi.org/10.1111/ejh.12004
38.
Kripp M, Willer A, Schmidt C, Pilz LR, Gencer D, Buchheidt D, Hochhaus A, Hofmann WK, Hofheinz RD: Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors. Ann Hematol 2014;93:317-325.
[PubMed]
https://doi.org/10.1007/s00277-013-1861-7
39.
Chou WC, Kao CY, Wang PN, Chang H, Wang HM, Chang PH, Yeh KY, Hung YS: The application of the Palliative Prognostic Index, Charlson Comorbidity Index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care. BMC Palliat Care 2015;14:18.
[PubMed]
https://doi.org/10.1186/s12904-015-0011-5
40.
LeBlanc TW, El-Jawahri A: Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care? Curr Opin Support Palliat Care 2018;12:530-537.
[PubMed]
https://doi.org/10.1097/SPC.0000000000000385
© 2018 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2018
You do not currently have access to this content.